SCHEMBL3901469

SCHEMBL3901469

CCc1oc(-c2cccc(OC)c2)cc1/C=C/C(=O)O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.45
HPGD P15428 2/20 0.45
ESR1 P03372 1/20 0.45
KDM4E B2RXH2 3/20 0.43
SMN1; SMN2 Q16637 3/20 0.43
CYP3A4 P08684 3/20 0.43
MAPK1 P28482 2/20 0.43
USP2 O75604 1/20 0.43
RECQL P46063 1/20 0.43
HSD17B10 Q99714 1/20 0.43
FAAH O00519 1/20 0.42
SLC9A1 P19634 1/20 0.42
HDAC8 Q9BY41 2/20 0.42
HDAC3 O15379 1/20 0.42
HDAC1 Q13547 1/20 0.42
HDAC2 Q92769 1/20 0.42
HDAC6 Q9UBN7 1/20 0.42
TP53 P04637 2/20 0.41
PTGER4 P35408 2/20 0.41
CYP2C9 P11712 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3901474 1.00 ALDH1A1 (0.45) ALDH1A1HPGDESR1KDM4ESMN1; SMN2
SCHEMBL13802273 0.88 CYP3A4 (0.54) ALDH1A1HPGDKDM4ESMN1; SMN2CYP3A4
SCHEMBL13791122 0.88 CYP3A4 (0.54) ALDH1A1HPGDKDM4ESMN1; SMN2CYP3A4
SCHEMBL3905767 0.83 ALDH1A1 (0.48) ALDH1A1HPGDKDM4ESMN1; SMN2CYP3A4
SCHEMBL3907152 0.76 VDR (0.48) ALDH1A1HPGDESR1KDM4ESMN1; SMN2
SCHEMBL3910193 0.74 KDM4E (0.44) ALDH1A1ESR1KDM4ECYP3A4CYP2C9
SCHEMBL3910194 0.74 KDM4E (0.44) ALDH1A1ESR1KDM4ECYP3A4CYP2C9
SCHEMBL3903128 0.74 KDM4E (0.46) ALDH1A1HPGDKDM4ESMN1; SMN2CYP3A4
SCHEMBL285246 0.73 PTGER4 (0.54) ALDH1A1SMN1; SMN2HSD17B10HDAC8PTGER4
SCHEMBL285247 0.73 PTGER4 (0.54) ALDH1A1SMN1; SMN2HSD17B10HDAC8PTGER4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7553867-B2 Furan or thiophene derivative and medicinal use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-06-30 US disclosed
US-20060100261-A1 Furan or thiopene derivative and medicinal use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED INTELLECTUAL PROPERTY DEPARTMENT (JP) 2006-05-11 US disclosed
EP-1535915-A1 FURAN OR THIOPHENE DERIVATIVE AND MEDICINAL USE THEREOF Takeda Pharmaceutical Company Limited (JP) 2005-06-01 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060100261-A1 Furan or thiopene derivative and medicinal use thereof TXN2, CYP11B2, CYP11B1 ALDH1A1 1096/4885HPGD 507/4885ESR1 1310/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.